Harm Reduction: the link between Australia’s new Hepatitis Strategies and the upcoming new National Drug Strategy (Online Event)
This event will feature presentations from: Rebecca Lang, Chair, AADC and CEO, QNADA – Why Harm Reduction is currently the most undervalued pillar of Australia’s National Drug Strategy Lucy Clynes, CEO, Hepatitis Australia – The new National Hepatitis Strategies – Priority Populations and Settings Ele Morrison, Deputy CEO, AIVL – How the harm reduction work […]